Pentwater Capital Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-724,856
Closed -$1.08M 120
2025
Q3
$1.08M Sell
724,856
-90,144
-11% -$159K 0.01% 92
2025
Q2
$1.58M Sell
815,000
-183,755
-18% -$241K 0.01% 78
2025
Q1
$1.22M Sell
998,755
-1,245
-0.1% -$3.06K 0.01% 90
2024
Q4
$3.02M Buy
1,000,000
+500,000
+100% +$1.41M 0.03% 77
2024
Q3
$1.26M Buy
500,000
+100,000
+25% +$356K 0.01% 76
2024
Q2
$1.88M Buy
400,000
+91,358
+30% +$482K 0.02% 73
2024
Q1
$1.75M Sell
308,642
-681,358
-69% -$4.49M 0.02% 77
2023
Q4
$6.55M Buy
990,000
+65,000
+7% +$376K 0.07% 63
2023
Q3
$7.4M Buy
925,000
+46,201
+5% +$429K 0.04% 60
2023
Q2
$8.9M Buy
878,799
+388,397
+79% +$3.97M 0.06% 60
2023
Q1
$5.22M Sell
490,402
-76,637
-14% -$845K 0.05% 92
2022
Q4
$6.52M Sell
567,039
-8,661
-2% -$77.6K 0.11% 65
2022
Q3
$4.91M Buy
575,700
+185,700
+48% +$1.54M 0.05% 86
2022
Q2
$2.73M Buy
390,000
+77,762
+25% +$646K 0.03% 118
2022
Q1
$3.63M Hold
312,238
0.04% 93
2021
Q4
$4M Buy
312,238
+1,022
+0.3% +$12.9K 0.04% 107
2021
Q3
$4.25M Buy
311,216
+9,382
+3% +$131K 0.04% 112
2021
Q2
$4.86M Buy
301,834
+26,834
+10% +$368K 0.04% 103
2021
Q1
$4.1M Sell
275,000
-6,864
-2% -$103K 0.04% 128
2020
Q4
$4.24M Hold
281,864
0.05% 90
2020
Q3
$4.66M Buy
281,864
+4,368
+2% +$61.3K 0.06% 87
2020
Q2
$3.6M Buy
277,496
+214,208
+338% +$2.81M 0.06% 62
2020
Q1
$495K Buy
63,288
+10,049
+19% +$136K 0.01% 105
2019
Q4
$689K Buy
+53,239
New +$651K 0.01% 116

Other funds holding TELA

Pentwater Capital Management's TELA Position: Q4 2025 in Review

Pentwater Capital Management sold out of TELA Bio (TELA) in Q4 2025, closing a stake of 724,856 shares — an estimated $1.08M sold.

Pentwater Capital Management first reported a position in TELA in Q4 2019 and held it in 24 quarters. The position peaked at $8.9M in Q2 2023. 42 funds tracked by Wall St. Rank hold TELA as of Q4 2025.

  • Pentwater Capital Management reported no remaining TELA Bio position as of Q4 2025 after selling out during the quarter.
  • Pentwater Capital Management sold 724,856 TELA Bio shares in Q4 2025, an estimated $1.08M.
  • Pentwater Capital Management first reported a position in TELA Bio in Q4 2019 and held it in 24 quarters.
  • Pentwater Capital Management's TELA Bio position peaked at $8.9M in Q2 2023.
  • 42 funds tracked by Wall St. Rank held TELA Bio as of Q4 2025.

Based on Pentwater Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.